Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. ULTA
8. NVDA
9. GAP
10. DG

Go back to Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights

Zynerba Pharma (ZYNE) Reports Q1 Loss of $0.60/Share

May 9, 2017 7:45 AM EDT

Zynerba Pharma (NASDAQ: ZYNE) reported Q1 EPS of ($0.60), versus ($0.49) reported last year.

Financial Outlook

The company believes that the current cash position of $77.5 million is sufficient to develop five Phase 3-ready programs and, assuming support from the FDA to move forward,... More